January 22, 2018 / 1:48 PM / a month ago

BRIEF-Juno Therapeutics Says If Deal Terminated By Co Or Celgene, Fee Of $300 Mln May Be Payable By Co To Celgene

Jan 22 (Reuters) - Celgene Corp:

* JUNO THERAPEUTICS SAYS IF DEAL TERMINATED BY CO OR CELGENE UPON SPECIFIED CONDITIONS, FEE OF $300 MILLION MAY BE PAYABLE BY CO TO CELGENE - SEC FILING

* JUNO THERAPEUTICS SAYS DEAL AGREEMENT PROVIDES CELGENE TO HAVE TO PAY CO REVERSE TERMINATION FEE OF $600 MILLION IF DEAL TERMINATED UNDER SOME CONDITIONS Source text: (bit.ly/2n0Tiwe) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below